NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity. The goal of this program is to improve management of patients with resectable early-stage non-small cell lung cancer (NSCLC) with neoadjuvant chemoimmunotherapy. After hearing and assimilating this program, the clinician will be better able to: 1. Select patients with NSCLC for treatment with neoadjuvant chemoimmunotherapy. 2. Relate levels of inflammatory markers in patients with NSCLC to likelihood of pathological complete response.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2024-01-25 06:00:00
- End Date: 2024-01-25 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
- MOC Credit Details: ABIM - 1.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest